Loading…
Novavax, Inc. is projected to rise to $16.61 by 2027, a +50% move from its current price of $11.09. NVAX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $10.63 | $11.10 | $11.58 | +0.05% |
| May 30 | $10.45 | $11.10 | $11.79 | +0.10% |
| May 31 | $10.32 | $11.11 | $11.95 | +0.15% |
| Jun 1 | $10.21 | $11.11 | $12.10 | +0.20% |
| Jun 2 | $10.11 | $11.12 | $12.22 | +0.25% |
| Jun 3 | $10.03 | $11.12 | $12.34 | +0.30% |
| Jun 4 | $9.95 | $11.13 | $12.45 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.95 | $11.13 | $12.45 | +0.35% |
| Week 2 | $9.53 | $11.17 | $13.09 | +0.69% |
| Week 3 | $9.23 | $11.21 | $13.61 | +1.04% |
| Week 4 | $8.98 | $11.24 | $14.07 | +1.39% |
| Week 5 | $8.78 | $11.28 | $14.50 | +1.75% |
| Week 6 | $8.60 | $11.32 | $14.90 | +2.10% |
| Week 7 | $8.44 | $11.36 | $15.29 | +2.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Novavax, Inc. is a biotechnology company that engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
It commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the COVID-19 vaccine.
Novavax was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. (NVAX) is currently trading with a price of $10.46 and a market capitalization of $1.72B. It is ranked 2136 by market cap among listed entities.
The current price sits in a forecast that envisions upside in coming years, with the 2026 average price at $10.46 and a potential rise toward higher levels in subsequent years, including a 2030 average of $24.14 and a 2050 average of $121.10.
Forecasts also show higher potential maximums across years, from a 2026 max of $14.71 up to a 2050 max of $268.88, indicating substantial upside in the longer horizon.
A major floor 38.1% below — a decisive break under it would weaken the trend.
The nearest floor, 28.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 19.1% above — clearing it would confirm fresh momentum.
Key NVAX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVAX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.80 | Buy | $10.08 | Buy |
| MA 10 | $9.45 | Buy | $9.66 | Buy |
| MA 20 | $9.12 | Buy | $9.30 | Buy |
| MA 50 | $8.83 | Buy | $9.00 | Buy |
| MA 100 | $8.93 | Buy | $8.77 | Buy |
| MA 200 | $8.37 | Buy | $8.50 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.77 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 214.53 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.17 | Buy |
| ROC (12) | 9.69 | Buy |
| Bollinger %B (20,2) | 1.10 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | 0.99 | Buy |
| Ultimate (7,14,28) | 76.43 | Sell |
| Momentum (10) | 1.47 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 10.29 | Buy |
| ADX (14) | 17.14 | Neutral |
| ATR (14) | 0.35 | Info |
The 30-day technical picture is bullish, as indicated by the current sentiment. RSI14 reads at 70, suggesting momentum strength near overbought levels.
Key moving averages are SMA50 at $8.81 and SMA200 at $8.36, placing the current price above both averages and signaling positive near-term momentum. Near-term support is at $7.92 and resistance at $10.46, with the 30-day trading range from $7.93 to $13.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.13 | $11.09 | $15.92 | 0% | Neutral | |
| $12.47 | $16.61 | $23.80 | +50% | Bullish | |
| $15.65 | $21.81 | $32.89 | +97% | Bullish | |
| $16.56 | $23.98 | $37.65 | +116% | Bullish | |
| $18.41 | $27.59 | $44.78 | +149% | Bullish | |
| $17.66 | $27.32 | $45.65 | +146% | Bullish | |
| $17.46 | $27.83 | $47.74 | +151% | Bullish | |
| $20.56 | $33.73 | $59.22 | +204% | Bullish | |
| $24.58 | $41.46 | $74.36 | +274% | Bullish | |
| $28.85 | $49.99 | $91.46 | +351% | Bullish | |
| $32.33 | $63.55 | $126.18 | +473% | Bullish | |
| $69.64 | $154.76 | $345.37 | +13.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.13 | $11.09 | $13.03 | +0.00% |
| June 2026 | $9.29 | $11.05 | $13.54 | -0.39% |
| July 2026 | $9.63 | $11.60 | $14.51 | +5.02% |
| August 2026 | $9.41 | $11.46 | $14.56 | -1.23% |
| September 2026 | $9.20 | $11.29 | $14.53 | -1.44% |
| October 2026 | $9.71 | $12.01 | $15.64 | +6.37% |
| November 2026 | $9.99 | $12.45 | $16.37 | +3.65% |
| December 2026 | $9.56 | $12.00 | $15.92 | -3.64% |
Click any year to see its month-by-month NVAX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NVAX is projected to trade between $7.13 and $15.92, averaging $11.09 — a potential gain of 0% from today's $11.09. Price action looks broadly range-bound.
Novavax, Inc.'s 2027 outlook centres on $16.61, within a $12.47 to $23.80 range. That is up +50% on the projected 2026 average. That marks a +50% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, NVAX could reach as high as $32.89, with a base case around $21.81 and support toward $15.65 — roughly +97% from $11.09. Momentum favours further upside here.
Expect NVAX to range from $16.56 to $37.65 through 2029. The $23.98 average target implies a +116% move from current prices. That is up +10% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NVAX price prediction for 2030 points to an average of $27.59 (low $18.41, high $44.78) — a potential gain of +149% on today's $11.09. Momentum favours further upside here.
In 2031, NVAX is projected to trade between $17.66 and $45.65, averaging $27.32 — a potential gain of +146% from today's $11.09. That is -1% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Novavax, Inc.'s 2032 outlook centres on $27.83, within a $17.46 to $47.74 range. That is up +2% on the projected 2031 average. That marks a +151% change versus current levels. Momentum favours further upside here.
By 2033, NVAX could reach as high as $59.22, with a base case around $33.73 and support toward $20.56 — roughly +204% from $11.09. Buyers look set to stay in control over this stretch.
Expect NVAX to range from $24.58 to $74.36 through 2034. The $41.46 average target implies a +274% move from current prices. That is up +23% on the projected 2033 average. Momentum favours further upside here.
The NVAX price prediction for 2035 points to an average of $49.99 (low $28.85, high $91.46) — a potential gain of +351% on today's $11.09. Buyers look set to stay in control over this stretch.
In 2040, NVAX is projected to trade between $32.33 and $126.18, averaging $63.55 — a potential gain of +473% from today's $11.09. That is up +27% on the projected 2035 average. Momentum favours further upside here.
Novavax, Inc.'s 2050 outlook centres on $154.76, within a $69.64 to $345.37 range. That is up +144% on the projected 2040 average. That marks a +13.0x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVAX today (≈ 90.171326 NVAX) could be worth
$13,954.74
+$12,954.74 (+1295%) by 2050 · US Dollar
Based on the average projected NVAX price of $154.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVAXwould be worth at today's price.
$1,000 invested in NVAX on May 27, 2025 (≈ 135.501353 NVAX) would be worth
$1,502.71
+$502.71 (+50.3%) today · 1.50× · US Dollar
Based on a NVAX entry price of $7.38 vs. today's $11.09.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.27 | $1,196.33 | +19.6% |
| 1 month ago | $8.07 | $1,374.23 | +37.4% |
| 3 months ago | $11.19 | $991.06 | -0.9% |
| 6 months ago | $7.05 | $1,573.05 | +57.3% |
| 1 year ago | $7.38 | $1,502.71 | +50.3% |
| All time (5.0y) ago | $145.4 | $76.27 | -92.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVAX forecast.
Our base-case forecast reaches $22.00 around 2029.
Implied market cap at $22.00: $3.62B
Year-by-year forecasts show a clear path of upside, beginning with a 2026 average of $10.46 and a 2026 min/max of $7.13/$14.71 (sentiment Neutral). By 2027 the average price rises to $14.95 with a ROI of 42.9 and a bullish outlook, expanding further in following years to $19.45 (2028), $21.20 (2029), and $24.14 (2030) with a ROI of 130.8.
In 2031 the average price is $23.63 and by 2032 it is $23.77, both with bullish sentiment, and 2033 shows an average of $28.34 with a ROI of 170.9. The forecast continues higher with 2034 at $34.09 (ROI 225.9) and 2035 at $41.10 (ROI 292.9), culminating in 2040 with an average of $50.73 (ROI 385) and 2050 with an average of $121.10 (ROI 1057.8) under bullish sentiment.
These are estimates and not guarantees, reflecting what the model anticipates as the price path over time.
Tap a question to reveal the answer.
2030: min 16.16, avg 24.14, max 39.08 with ROI 130.8 and sentiment BULLISH.
Forecasts show rising averages from 2026 onward, with the 2027 average at 14.95 and the 2030 average at 24.14, culminating in a 2050 average of 121.10 and 2050 max of 268.88, all under bullish sentiment. These are estimates, not guarantees.
Yes. The forecast shows year max values such as 2034 max 60.91, 2040 max 100.29, and 2050 max 268.88, indicating potential to reach higher price levels over time.
Sentiment is BULLISH. RSI14 is 70. SMA50 is $8.81 and SMA200 is $8.36. Support is $7.92 and resistance is $10.46, with a 30-day range from $7.93 to $13.79.
Current price is $10.46. Market cap is $1.72B, and the rank is 2136.
Novavax, Inc. Community Discussion
0Share your Novavax, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.